CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION


如何引用文章

全文:

详细

Interrelations between signs of chronic kidney disease and atrial fibrillation are discussed.

作者简介

V Fomin

G Kiyakbaev

参考

  1. Ronco C., McCullough P., Anker S. et al.; Acute Dialysis Quality Initiative consensus group. Eur. Heart J. 2010; 31: 703 - 711
  2. Watanabe H., Watanabe T., Sasaki S. et al. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J. 2009; 158(4): 629-636
  3. Soliman E.Z., Prineas R.J., Go A.S. et al.; Chronic Renal Insufficiency Cohort (CRIC) Study Group. Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). Am. Heart J. 2010; 159(6): 1102-1107
  4. Horio T., Iwashima Y., Kamide K. et al. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients. J. Hypertens. 2010; 28(8): 1738-1744
  5. Iguchi Y., Kimura K., Kobayashi K. et al. Relation of atrial fibrillation to glomerular filtration rate. Am. J. Cardiol. 2008; 102(8):1056-1059
  6. McManus D.D., Corteville D.C., Shlipak M.G. et al. Relation of kidney function and albuminuria with atrial fibrillation (from the Heart and Soul Study). Am. J. Cardiol. 2009; 104(11): 1551-1555
  7. Baber U., Howard V.J., Halperin J.L. et al. Association of Chronic Kidney Disease with Atrial Fibrillation Among Adults in the United States: Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Circ. Arrhythm. Electrophysiol. 2010 Nov 13. [Epub ahead of print]
  8. Deo R., Katz R., Kestenbaum B. et al. Impaired kidney function and atrial fibrillation in elderly subjects. J. Card. Fail. 2010; 16(1): 55-60
  9. Ananthapanyasut W., Napan S., Rudolph E.H. et al. Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2010; 5(2): 173-181
  10. Шутов А.М., Серов В.А., Курзина Е.В. и др. Хроническая болезнь почек и фибрилляция предсердий у больных с хронической сердечной недостаточностью. Тер. арх. 2009; 12; 23-26
  11. Marín R., Rodríguez P., Tranche S. et al.; MAGAL group. Prevalence of abnormal urinary albumin excretion rate in hypertensive atients with impaired fasting glucose and its association with cardiovascular disease. J. Am. Soc. Nephrol. 2006; 17(12 Suppl 3): S178-S188
  12. Tebbe U., Bramlage P., Thoenes M. et al. Prevalence of microalbuminuria and its associated cardiovascular risk: German and Swiss results of the recent global i-SEARCH survey. Swiss Med. Wkly. 2009; 139(33-34): 473-480
  13. Asselbergs F.W., van den Berg M.P., Diercks G.F. et al. C-reactive protein and microalbuminuria are associated with atrial fibrillation. Int. J. Cardiol. 2005; 98(1): 73-77
  14. Asselbergs F.W., van den Berg M.P., Bakker SJ. et al. N-terminal pro B-type natriuretic peptide levels predict newly detected atrial fibrillation in a population-based cohort. Neth. Heart J. 2008; 16(3): 73-78
  15. Wozakowska-Kapłon B., Opolski G., Herman Z., Kosior D. Natriuretic peptides in patients with atrial fibrillation. Cardiol. J. 2008; 15(6): 525-529
  16. Sakuma M., Nakamura M., Tanaka F. et al. Plasma B-type natriuretic peptide level and cardiovascular events in chronic kidney disease in a community-based population. Circ. J. 2010 Feb 17. [Epub ahead of print]
  17. Böhm M., Thoenes M., Neuberger HR. et al. Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients. Eur. Heart J. 2009; 30(11): 1364-1371
  18. Naruse Y., Tada H., Sekiguchi Y. et al. Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: a mid-term follow-up. Heart Rhythm. 2010 Nov 3. [Epub ahead of print]
  19. Bukowska A., Lendeckel U., Krohn A. et al. Atrial fibrillation down-regulates renal neutral endopeptidase expression and induces profibrotic pathways in the kidney. Europace. 2008; 10(10): 1212-1217
  20. Lentine K.L., Schnitzler M.A., Abbott K.C. et al. Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation. Clin. J. Am. Soc. Nephrol. 2006; 1(2): 288-296
  21. Сыркин А.Л., Сулимов В.А., Фомина И.Г. и др.; рабочая группа экспертов ВНОК. Диагностика и лечение фибрилляции предсердий. Кардиоваскулярная терапия и профилактика. 2005; 4(4) Приложение 1.
  22. Go A.S., Fang M.C., Udaltsova N. et al. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation. 2009; 119(10): 1363-1369
  23. Reinecke H., Brand E., Mesters R. et al. Dilemmas in the management of atrial fibrillation in chronic kidney disease. J. Am. Soc. Nephrol. 2009; 20(4): 705-711
  24. Go A.S., Hylek E.M., Phillips K.A. et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. J.A.M.A. 2001; 285(18): 2370-2375
  25. Mant J., Hobbs F.D., Fletcher K. et al.; BAFTA investigators; Midland Research Practices Network (MidReC). Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet. 2007; 370(9586): 493-503
  26. Rietbrock S., Plumb J.M., Gallagher A.M., van Staa T.P. How effective are dose-adjusted warfarin and aspirin for the prevention of stroke in patients with chronic atrial fibrillation? An analysis of the UK General Practice Research Database. Thromb. Haemost. 2009; 101(3): 527-534
  27. Rash A., Downes T., Portner R. et al. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO). Age Ageing. 2007; 36(2): 151-156
  28. Andersen L.V., Vestergaard P., Deichgraeber P. et al. Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis. Heart. 2008; 94(12): 1607-1613
  29. Sood M.M., Komenda P., Sood A.R. et al. The intersection of risk and benefit: is warfarin anticoagulation suitable for atrial fibrillation in patients on hemodialysis? Chest. 2009; 136(4): 1128-1133
  30. Quinn R.R., Naimark D.M., Oliver M.J., Bayoumi A.M. Should hemodialysis patients with atrial fibrillation undergo systemic anticoagulation? A cost-utility analysis. Am. J. Kidney Dis. 2007; 50(3): 421-432
  31. Healey J.S., Baranchuk A., Crystal E. et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J. Am. Coll. Cardiol. 2005; 45(11): 1832-1839

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##